{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Prajapati M"],"funding":["NCRR NIH HHS","NIDDK NIH HHS","National Institutes of Health","NIGMS NIH HHS"],"pagination":["105732"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10933546"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["300(3)"],"pubmed_abstract":["The manganese (Mn) export protein SLC30A10 is essential for Mn excretion via the liver and intestines. Patients with SLC30A10 deficiency develop Mn excess, dystonia, liver disease, and polycythemia. Recent genome-wide association studies revealed a link between the SLC30A10 variant T95I and markers of liver disease. The in vivo relevance of this variant has yet to be investigated. Using in vitro and in vivo models, we explore the impact of the T95I variant on SLC30A10 function. While SLC30A10 I95 expressed at lower levels than T95 in transfected cell lines, both T95 and I95 variants protected cells similarly from Mn-induced toxicity. Adeno-associated virus 8-mediated expression of T95 or I95 SLC30A10 using the liver-specific thyroxine binding globulin promoter normalized liver Mn levels in"],"journal":["The Journal of biological chemistry"],"pubmed_title":["AAV-mediated hepatic expression of SLC30A10 and the Thr95Ile variant attenuates manganese excess and other phenotypes in Slc30a10-deficient mice."],"pmcid":["PMC10933546"],"funding_grant_id":["P30 RR031153","R01 DK110049","P30 GM103410","P20 RR018728"],"pubmed_authors":["Zhang JZ","Bartnikas TB","Chiu L","Ma B","Ward LD","Prajapati M","Chong GS","Quenneville CB","Tu HC"],"additional_accession":[]},"is_claimable":false,"name":"AAV-mediated hepatic expression of SLC30A10 and the Thr95Ile variant attenuates manganese excess and other phenotypes in Slc30a10-deficient mice.","description":"The manganese (Mn) export protein SLC30A10 is essential for Mn excretion via the liver and intestines. Patients with SLC30A10 deficiency develop Mn excess, dystonia, liver disease, and polycythemia. Recent genome-wide association studies revealed a link between the SLC30A10 variant T95I and markers of liver disease. The in vivo relevance of this variant has yet to be investigated. Using in vitro and in vivo models, we explore the impact of the T95I variant on SLC30A10 function. While SLC30A10 I95 expressed at lower levels than T95 in transfected cell lines, both T95 and I95 variants protected cells similarly from Mn-induced toxicity. Adeno-associated virus 8-mediated expression of T95 or I95 SLC30A10 using the liver-specific thyroxine binding globulin promoter normalized liver Mn levels in","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2026-07-15T10:42:50.453Z","creation":"2025-02-19T04:41:23.79Z"},"accession":"S-EPMC10933546","cross_references":{"pubmed":["38336290"],"doi":["10.1016/j.jbc.2024.105732"]}}